SER-287 (SERES-101 Study) microbial therapy for UC

I am curious is anyone is participating, or knows anyone participating in this clinical trial:

https://www.clinicaltrials.gov/ct2/show/NCT02618187?term=SERES-101&rank=1

A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Ulcerative Colitis

Detailed Description:
This is a Phase 1b multicenter, randomized, double-blind, placebo-controlled multiple dose study designed to evaluate the safety and tolerability of SER-287, and to evaluate the microbiome alterations and pharmacodynamics associated with 2 dosing regimens of SER-287 in adult subjects with mild-to-moderate ulcerative colitis (UC).